The Arab Drug Company

Equities

ADCI

EGS38321C013

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
94.19 ^EGP	0.00%		0.00%	+35.27%

Feb. 14	The Arab Drug Company Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

Arab Pharmaceuticals Reports Earnings Results for the Nine Months Ended March 31, 2017

May 13, 2017

Arab Pharmaceuticals reported earnings results for the nine months ended March 31, 2017. For the period, the company reported net profit EGP 17,603,875 compared to EGP 4,479,898 a year ago.

Latest news about The Arab Drug Company

The Arab Drug Company Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 14	CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 13	CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-14	CI
The Arab Drug Company Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-15	CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-15	CI
The Arab Drug Company Reports Earnings Results for the Full Year Ended June 30, 2021	21-09-01	CI
The Arab Drug Company Reports Financial Results for the Period from July 1, 2020 to March 31, 2021	21-05-19	CI
The Arab Drug Company Reports Earnings Results for the Six Months Ended December 31, 2020	21-02-11	CI
The Arab Drug Company Announces Unaudited Earnings Results for the Full Year Ended June 30, 2020	20-07-12	CI
The Arab Drug Company Reports its Financial Results for the Period from July 1, 2019 to March 31, 2020	20-05-16	CI
Arab Drug Company Announces Earnings Results for the Nine Months Ended 31 March 2020	20-04-12	CI
The Arab Drug Company Reports Its Financial Results for the Period from July 1, 2019 to September 30, 2019	19-11-06	CI
Arab Pharmaceuticals Announces Earnings Results for the Quarter Ended March 31, 2019	19-05-13	CI
Arab Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2018	19-02-10	CI
Arab Pharmaceuticals Reports Earnings Results for the Quarter Ended September 30, 2018	18-11-07	CI
The Arab Drug Company Announces Cash Dividend, Payable October 28, 2018	18-10-08	CI
Arab Pharmaceuticals Reports Audited Earnings Results for Year Ended June 30, 2018	18-08-29	CI
Arab Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2018	18-05-08	CI
The Arab Drug Company Reports Earnings Results for the Six Months Ended December 31, 2017	18-02-08	CI
Arab Pharmaceuticals Reports Earnings Results for the First Quarter Ended September 30, 2017	17-11-12	CI
Arab Pharmaceuticals Declares Cash Dividend, Payable on October 26, 2017	17-10-10	CI
The Arab Drug Company Reports Audited Earnings Results for the Year Ended June 30, 2017	17-09-06	CI
Arab Pharmaceuticals Reports Earnings Results for the Nine Months Ended March 31, 2017	17-05-13	CI
Arab Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2016	17-02-07	CI

Chart The Arab Drug Company

Duration

Period

More charts

Company Profile

Arab Drug Company for Pharmaceuticals and Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical and veterinary products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
THE ARAB DRUG COMPANY	+35.27%	12.06M
NOVO NORDISK A/S	+31.37%	588B
JOHNSON & JOHNSON	-2.73%	364B
MERCK & CO., INC.	+20.41%	326B
ABBVIE INC.	+5.48%	285B
ASTRAZENECA PLC	+14.83%	239B
NOVARTIS AG	+9.93%	210B
ROCHE HOLDING AG	-6.95%	200B
AMGEN INC.	+11.13%	167B
PFIZER, INC.	+0.45%	161B

Other Pharmaceuticals